908 organization(s) found
British Society of Haematology (BSH)
The British Society for Haematology (BSH) has been bringing haematology professionals together since 1960 to transform the care our members provide to patients. With over 3,000 members worldwide, we are the largest UK haematology organisation and the only society to cover all aspects of the speciality. Listening: Our members work together to share ideas and knowledge and to champion and strengthen haematology practice Learning: Together we help shape the future of haematology by providing access to resources, events and education that support your professional development Leading: Bridging the gap between research and practice, our guidelines raise the standards of clinical and patient care
Broad Institute of MIT and Harvard
Biomedical and genomics research institute.
Byondis
"Byondis's ambition is to become a leading pharmaceutical company by discovering, developing and delivering proprietary breakthrough medicinal modalities to patients in the field of cancer and other difficult to treat diseases." - Jacques Lemmens, PhD, Founder / Chairman of the Board
CAB (Cancer Association of Botswana)
Volunteer-run NGO established in 1998 to reduce the impact of cancer by promoting early detection, awareness, counseling, and support including temporary accommodation for patients during treatment.
CACA (China Anti-Cancer Association)
The Chinese Anti-Cancer Association (CACA), founded in 1984, has a mission to unite people involved in all branches of oncology and others with a similar interest in fighting cancer. CACA aims its utmost efforts at organizing scientific cooperation and conferences, promoting international non-governmental exchanges, conducting various training courses and seminars, fostering scientific, technological and medical personnel in the field of oncology, compiling and publishing academic periodicals, and mobilizing social forces to take part in popularization and dissemination of the knowledge of tumor prevention. Globally, the association is interested in organizing academic meetings with international colleagues in order to cultivate friendly ties with overseas oncology organizations and individuals. The Chinese Anti-Cancer Association has been a full UICC member since January 1997.
Callio Therapeutics
We are developing next-generation, multi-payload antibody-drug conjugates (ADCs) that feature differentiated payload and linker technologies. This enables targeted delivery of drug combinations to tumor cells to maximize therapeutic benefit for cancer patients. Our lead program is a dual-payload HER2-targeted ADC.
Cancer Hospital (Third Affiliated Hospital) of Xinjiang Medical University
Regional cancer hospital in northwest China; participates in national networks for clinical trials and cancer care. (CareAcross)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences (CAMS Cancer Hospital, Beijing)
National-level top oncology hospital and research centre; historically designated a WHO Collaborating Centre for cancer research and control. It has played key roles in cancer epidemiology, control programmes, training, and research in China. (Iris)
Cancéropôle Est
In French: "Plus de 200 équipes sont mobilisées dans un seul but : développer une recherche compétitive et innovante dans le domaine de la lutte contre le cancer. Au total, 1000 chercheurs et cliniciens unissent leurs efforts afin de faire bénéficier les 8,4 millions d’habitants de l’interrégion Est des avancées en termes de prévention, dépistage, diagnostic et thérapeutique."
Cancéropôle Grand-Ouest
In French: "Le Cancéropôle Grand-Ouest stimule la recherche translationnelle en favorisant la collaboration entre les laboratoires de recherche fondamentale et les unités cliniques, générant ainsi des projets pluridisciplinaires et ambitieux pour permettre aux patients de bénéficier plus rapidement des traitements innovants, tout en contribuant à la structuration et l'attractivité de l'inter-région GO au niveau national et international."
Cancéropôle Grand Sud-Ouest (GSO)
Regional structure that coordinates cancer research teams in the south-west of France.
Cancéropôle Île-de-France
Dans le cadre de sa mission d’animation du réseau francilien de recherche en cancérologie, le Cancéropôle Île-de-France propose et relaye toute l’année les annonces de séminaires scientifiques, appels à projets, formations et autres actualités susceptibles d’intéresser les cliniciens et chercheurs franciliens travaillant dans le domaine du cancer, ainsi que les patients et représentants de patients, ou les représentants institutionnels et administratifs.
Cancéropôle Nord-Ouest
In French: "Le Cancéropôle Nord-Ouest (CNO) est une initiative lancée et financée dans le cadre des Plans Cancers nationaux pour soutenir la recherche sur le cancer à l’échelle interrégionale. Relais de terrain, connaissant bien son territoire et ses partenaires institutionnels, il mobilise contre le cancer à l’échelle des Hauts-de-France et de la Normandie. La structure dispose d’un excellent potentiel de recherche, tant au niveau fondamental que translationnel et clinique collaborant autour du thème fédérateur « Du dépistage des tumeurs à l’innovation thérapeutique »."
Canceropôle PACA
In French: "Groupement d’intérêt public, le Canceropôle réunit et sert la communauté académique, scientifique, médicale et industrielle de Provence-Alpes-Côte d’Azur. Depuis 2003, nous agissons au cœur d’un écosystème d’excellence, pour concrétiser la politique nationale de lutte contre les cancers dans une stratégie régionale au bénéfice des patients. Notre mission : propulser les recherches et innovations anticancers, des découvertes fondamentales aux applications thérapeutiques. À l’écoute des besoins, nous animons, soutenons, accompagnons les chercheurs et les équipes dans différentes disciplines pour accélérer l’avancée vers les thérapies de demain. Nous favorisons la maturation et le transfert des résultats de recherche vers la médecine et l’industrie, pour développer plus vite de nouveaux outils, diagnostics et traitements."
Cancer Research Institute (CRI)
US non-profit organisation that funds research on cancer immunotherapy.
CANSA (Cancer Association of South Africa)
Non-profit leader in the fight against cancer; enables research, education, public awareness, support and advocacy for all cancer patients in South Africa.
Caribou Biosciences
Biotechnology company that develops allogeneic CAR-T cell therapies for blood cancers.
Carisma Therapeutics
Carisma's innovative approach has the potential to create life-changing therapies for patients with fibrosis, oncology and autoimmune disorders.
CARsgen Therapeutics
CARsgen Therapeutics is a biopharmaceutical company focusing on developing innovative CAR T-cell therapies to address the unmet clinical needs including but not limited to hematologic malignancies, solid tumors and autoimmune diseases. As one of the leading companies in the field of CAR T-cell therapies, CARsgen has established end-to-end capabilities for CAR T-cell research and development covering target discovery, preclinical research, product clinical development, and commercial-scale production.